PDO
- Product code
- PDO
- Device name
- Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization
- Device class
- Class 2
- 21 CFR
- 21 CFR 864.1870
- Medical specialty
- Hematology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
The EGR1 FISH Probe Kit for specimen characterization detects the LSI EGR1 probe target on chromosome 5q in bone marrow specimens. This assay is used to characterize bone marrow specimens from patients with acute myeloid leukemia (AML) or myelodysplastic syndrome. The assay results are to be interpreted by a qualified pathologist or cytogeneticist.
Official FDA classification page: PDO
Classification and pathway per current FDA publications. Data from openFDA (CC0).